◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Waverley Pharma Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 475,373 412,090 1.2M 1.8M
Operating Revenue 475,373 412,090 1.2M 1.8M
Cost Of Revenue 261,329 332,289 963,043 1.5M
Gross Profit 214,044 79,801 283,789 222,669
Selling General And Administration 652,337 1.1M 1.1M 983,872
Research And Development 423,659 234,578 81,656 25,623
Operating Expense 957,617 1.3M 921,945 1.0M
Operating Income -743,573 -1.2M -638,156 -786,826
EBIT -784,538 -2.1M -638,156 -786,826
Interest Expense 162,539 76,899 -- --
Interest Expense Non Operating 162,539 76,899 -- --
Interest Income 1,077 1,522 -- --
Interest Income Non Operating 1,077 1,522 -- --
Net Interest Income -162,405 -76,653 -16,638 -3,037
Other Income Expense -41,099 -913,511 -9,282 -6,644
Other Non Operating Income Expenses -- 29,690 297,989 41,977
Special Income Charges 0.00 -942,623 0.00 --
Gain On Sale Of Security -41,099 -578.00 -9,282 -48,621
Pretax Income -947,077 -2.2M -664,076 -796,507
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -947,077 -2.2M -664,076 -796,507
Net Income From Continuing Operation Net Minority Interest -947,077 -2.2M -664,076 -796,507
Net Income Including Noncontrolling Interests -947,077 -2.2M -664,076 -796,507
Net Income Common Stockholders -947,077 -2.2M -664,076 -796,507
Net Income -947,077 -2.2M -664,076 -796,507
EBITDA -656,129 -1.7M -426,052 -716,572
Normalized EBITDA -615,030 -777,664 -416,770 -667,951
Reconciled Depreciation 128,409 426,284 212,104 70,254
Basic EPS -0.02 -0.04 -0.01 -0.01
Diluted EPS -0.02 -0.04 -0.01 -0.01
Basic Average Shares 54.0M 54.0M 54.0M 54.0M
Diluted Average Shares 54.0M 54.0M 54.0M 54.0M
Total Unusual Items -41,099 -943,201 -9,282 -48,621
Total Unusual Items Excluding Goodwill -41,099 -943,201 -9,282 -48,621
Tax Rate For Calcs 0.00 0.00 0.00 0.00
Normalized Income -905,978 -1.3M -654,794 -747,886
Diluted NI Availto Com Stockholders -947,077 -2.2M -664,076 -796,507
Impairment Of Capital Assets 0.00 942,623 0.00 --
Net Income Continuous Operations -947,077 -2.2M -664,076 -796,507
Net Non Operating Interest Income Expense -162,405 -76,653 -16,638 -3,037
Other Taxes -118,379 -48,952 -297,989 0.00
Reconciled Cost Of Revenue 261,329 332,289 963,043 1.5M
Total Expenses 1.2M 1.6M 1.9M 2.5M
Total Other Finance Cost 943.00 1,276 16,638 3,037
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 235,929 53,015 133,797 158,115
Cash Cash Equivalents And Short Term Investments 235,929 53,015 133,797 158,115
Cash Financial 235,929 53,015 133,797 158,115
Accounts Receivable 53,062 135,321 190,998 424,368
Receivables 208,681 138,197 193,398 702,046
Inventory 261,485 633.00 61,522 330,191
Prepaid Assets 23,625 224,880 243,803 255,592
Current Assets 729,720 416,725 632,520 1.4M
Gross PPE 271,763 0.00 -- --
Accumulated Depreciation -8,367 0.00 -- --
Net PPE 263,396 0.00 -- --
Goodwill 223,560 0.00 -- --
Goodwill And Other Intangible Assets 621,504 0.00 1.7M 1.8M
Other Intangible Assets 397,944 264,520 1.7M 1.8M
Other Non Current Assets 431,189 535,568 375,427 479,806
Total Non Current Assets 1.3M 535,568 2.1M 2.2M
Total Assets 2.0M 952,293 2.7M 3.7M
Current Debt 2.8M 1.6M 701,726 262,356
Current Debt And Capital Lease Obligation 2.8M 1.6M 701,726 262,356
Accounts Payable 1.0M 486,969 736,510 1.1M
Payables 1.0M 486,969 894,541 1.6M
Payables And Accrued Expenses 1.0M 486,969 894,541 1.6M
Current Liabilities 3.9M 2.1M 1.6M 1.9M
Long Term Debt And Capital Lease Obligation 218,912 0.00 -- --
Long Term Capital Lease Obligation 218,912 0.00 -- --
Total Non Current Liabilities Net Minority Interest 218,912 0.00 0.00 0.00
Total Liabilities Net Minority Interest 4.1M 2.1M 1.6M 1.9M
Common Stock 7.0M 7.0M 7.0M 7.0M
Capital Stock 7.0M 7.0M 7.0M 7.0M
Additional Paid In Capital 809,420 809,420 809,420 809,420
Retained Earnings -10.3M -9.4M -7.2M -6.5M
Gains Losses Not Affecting Retained Earnings -20,755 -73,005 -69,236 -35,230
Common Stock Equity -2.0M -1.1M 1.1M 1.8M
Stockholders Equity -2.0M -1.1M 1.1M 1.8M
Total Equity Gross Minority Interest -2.0M -1.1M 1.1M 1.8M
Total Capitalization -2.0M -1.1M 1.1M 1.8M
Net Tangible Assets -2.7M -1.1M -588,320 30,884
Tangible Book Value -2.7M -1.1M -588,320 30,884
Working Capital -3.1M -1.7M -963,747 -448,922
Invested Capital 778,821 465,324 1.8M 2.1M
Total Debt 3.1M 1.6M 701,726 262,356
Net Debt 2.6M 1.5M 567,929 104,241
Share Issued 54.0M 54.0M 54.0M 54.0M
Ordinary Shares Number 54.0M 54.0M 54.0M 54.0M
Capital Lease Obligations 256,028 0.00 -- --
Current Capital Lease Obligation 37,116 0.00 -- --
Finished Goods 261,485 633.00 61,522 330,191
Line Of Credit 2.8M 1.6M 661,726 222,356
Machinery Furniture Equipment 10,072 0.00 -- --
Other Current Borrowings -- -- 40,000 40,000
Other Equity Interest 521,894 521,894 521,894 521,894
Other Payable -- -- 158,031 570,510
Other Properties 261,691 -- -- --
Other Receivables 155,619 2,876 2,400 277,678
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow -410,192 -1.0M -237,063 -798,778
Cash Flow From Continuing Operating Activities -410,192 -1.0M -237,063 -798,778
Depreciation And Amortization 128,409 426,284 212,104 70,254
Depreciation Amortization Depletion 128,409 426,284 212,104 70,254
Stock Based Compensation -- -- 0.00 261.00
Deferred Tax 0.00 -48,952 -297,989 --
Deferred Income Tax 0.00 -48,952 -297,989 --
Change In Working Capital 363,288 -152,520 510,745 -90,615
Changes In Account Receivables -75,447 55,201 275,382 -246,110
Change In Receivables -75,447 55,201 275,382 -246,110
Change In Inventory -28,846 60,889 293,096 -64,509
Change In Payables And Accrued Expense 266,326 -249,687 -28,872 225,890
Other Non Cash Items 162,405 46,963 16,638 3,037
Purchase Of Business -611,550 0.00 -- --
Investing Cash Flow -611,550 0.00 -226,625 0.00
Cash Flow From Continuing Investing Activities -611,550 0.00 -226,625 0.00
Issuance Of Debt -- 940,333 439,370 222,356
Repayment Of Debt -9,881 -- -- --
Net Issuance Payments Of Debt 1.2M 940,333 439,370 222,356
Financing Cash Flow 1.2M 940,333 439,370 222,356
Cash Flow From Continuing Financing Activities 1.2M 940,333 439,370 222,356
Effect Of Exchange Rate Changes 6,213 0.00 0.00 24,045
Changes In Cash 176,701 -80,782 -24,318 -576,422
Beginning Cash Position 53,015 133,797 158,115 710,492
End Cash Position 235,929 53,015 133,797 158,115
Free Cash Flow -410,192 -1.0M -237,063 -798,778
Amortization Cash Flow 120,307 426,284 212,104 70,254
Amortization Of Intangibles 120,307 426,284 212,104 70,254
Asset Impairment Charge 0.00 1.0M 0.00 16,948
Change In Prepaid Assets 201,255 -18,923 -28,861 -5,886
Depreciation 8,102 0.00 -- --
Interest Paid Cfo -158,316 -78,175 -14,485 -2,156
Interest Received Cfo -- -- -- -2,156
Long Term Debt Issuance -- 940,333 439,370 222,356
Long Term Debt Payments -9,881 -- -- --
Net Business Purchase And Sale -611,550 0.00 -- --
Net Foreign Currency Exchange Gain Loss 41,099 578.00 -- --
Net Income From Continuing Operations -947,077 -2.2M -664,076 -796,507
Net Long Term Debt Issuance -9,881 940,333 439,370 222,356
Net Other Investing Changes -- -- -226,625 --
Net Short Term Debt Issuance 1.2M 940,333 -- --
Operating Gains Losses 41,099 578.00 -- --
NEWS
Loading news...
TRENDING
Loading...